导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | -17.98% | 4249/4762 |
| 近一周 | -3.74% | 4867/5451 |
| 近一月 | -4.12% | 3031/5408 |
| 近一季 | -0.86% | 1138/5218 |
| 近半年 | -18.34% | 4285/4907 |
| 近一年 | -22.12% | 3975/4387 |
| 近两年 | 22.85% | 2585/2950 |
| 近三年 | -1.13% | 1941/2249 |
| 成立以来 | -20.91% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-5.57% 3876/4961 |
-14.40% 4572/5312 |
- - |
- - |
| 2025 | 18.80% 2279/4813 |
4.01% 1010/3635 |
4.97% 673/4076 |
14.38% 2911/4524 |
-4.87% 3490/4813 |
| 2024 | 7.91% 1606/3463 |
4.99% 409/2808 |
-14.33% 2661/3014 |
20.70% 678/3129 |
-0.60% 1474/3463 |
| 2023 | -0.77% 474/2656 |
23.94% 107/2280 |
-0.67% 401/2385 |
-13.37% 2148/2515 |
-6.95% 1989/2655 |
| 2022 | -19.81% 903/2207 |
-18.96% 1416/1919 |
5.65% 851/2016 |
-14.42% 1092/2113 |
9.45% 220/2208 |
| 2021 | -6.39% 1008/1822 |
-0.87% 402/1255 |
-2.76% 1227/1330 |
-15.78% 1391/1466 |
15.31% 64/1822 |
| 2020 | 17.93% 753/1250 |
-8.51% 617/1028 |
26.05% 149/1067 |
5.00% 935/1164 |
-2.61% 1123/1184 |
| 2019 | 22.42% 642/1092 |
21.46% 599/754 |
-10.78% 747/804 |
1.38% 408/850 |
11.43% 61/918 |
| 2018 | -32.20% 524/834 |
- - |
- - |
- - |
-7.79% 71/691 |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 万家中证港股通创新药ETF | 1.5896 | 28.31% |
| 景顺长城中证港股通创新药ETF | 1.6507 | 28.23% |
| 港股医疗 | 0.9366 | 28.18% |
| 港股医疗ETF | 1.4282 | 28.15% |
| 港股通医疗ETF工银 | 0.9464 | 28.06% |
| 港股通医疗ETF华宝 | 0.9577 | 27.97% |
| 天弘恒生沪深港创新药精选50ETF发起联接C | 1.2844 | 27.92% |
| 天弘恒生沪深港创新药精选50ETF | 0.8437 | 27.35% |
| 万家中证港股通创新药ETF发起式联接A | 1.3863 | 27.32% |
| 万家中证港股通创新药ETF发起式联接C | 1.3856 | 27.27% |
| 富国中证娱乐主题指数增强(LOF)A VS. 长安沪深300非周期A(740101) |